This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Te Pū rauemi KOWHEORI-19 COVID-19 resource hub

Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.

Kia āta kōwhiri Choosing Wisely

The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.

Back to previous page

Guidelines for Applications for a Director-General's Waiver to allow Electronic Prescribing

Medicines (Reducing harm)
10 December 2011

While the electronic transmission of prescriptions is not permitted under the Medicines Regulations 1984 or the Electronic Transactions Act 2002, the Director-General of Health can issue a waiver on a case-by-case basis.  On 1 August 2011, the waiver provision in the Medicines Regulations 1984 was updated.  

A waiver application must include a business case and project plan setting out the timeframes for implementation. The attached guidelines set out the requirements and information a waiver application must meet. They include:

  • consistency with the National Health IT Plan and other electronic prescribing and safer use of medicines initiatives
  • security and authentication requirements
  • the identification and rationale for any inconsistencies with legislative requirements, contract/funding requirements and/or the Pharmaceutical Schedule.

Relevant pages